The free event will be held March 1 at Railroad Park and includes a 5K and fun run.

New guidelines create clarity of language that will help advance mitochondria transfer and transplantation research for therapeutic innovations.

This polygenic score predicts tamoxifen treatment resistance is better than conventional methods, with potential for personalized medicine application.

UAB researchers are pioneering five new projects as they continue making new discoveries and advancing science to benefit oral health locally and globally.

This devastating neurodevelopmental disorder has no currently approved treatments.

A new artificial intelligence center will bring more discovery in the field to UAB.

The award is the highest honor given by the ACMG Foundation for Genetic and Genomic Medicine.

Description of this mechanism offers a promising therapeutic target to limit lung injury and death. Lower respiratory tract infections, including bacterial pneumonia, are the fourth-leading cause of death worldwide, with 120 million to 156 million cases and 1.4 million deaths a year.

The clinically approved drug ruxolitinib suppressed a mouse model of melanoma that is resistant to immune checkpoint blockers.

In response to a viral infection, intrinsic IL-2 production by effector CD8 T cells affects IL-2 signaling, leading to different fates for two subsets of those cells — the one producing IL-2 and the one not producing IL-2.

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.

The higher infectivity correlates with mutations that increase viral binding to a cell surface glucosaminoglycan, heparan sulfate.

The Altec Styslinger Genomic Medicine and Data Sciences Building will help cement UAB’s place as a leading research institution in genomic and precision medicine.

Study points to a potential immediate treatment for this devastating disease.

UAB researchers have found a previously unknown gene variant that appears to contribute to movement disorders.

A gene mutation causes wrinkled skin and hair loss; turning off that mutation restores the mouse to normal appearance.

The partnership combines genomics expertise with leadership in research and clinical medicine to speed efforts to deliver personalized therapies and cures.

Newfound details of rare disease may advance understanding of brain tumors.

Quirky evolution yields clues to a fatal condition.